153 related articles for article (PubMed ID: 6903579)
1. Relative resistance of the F-42-stabilized classical pathway C3 convertase to inactivation by C4-binding protein.
Daha MR; van Es LA
J Immunol; 1980 Nov; 125(5):2051-4. PubMed ID: 6903579
[TBL] [Abstract][Full Text] [Related]
2. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
3. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
4. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Vanes LA
Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Vanes LA; Cats A
Immunology; 1980 Jul; 40(3):417-24. PubMed ID: 6903557
[TBL] [Abstract][Full Text] [Related]
6. Regulation and deregulation of the fluid-phase classical pathway C3 convertase.
Gigli I; Sorvillo J; Halbwachs-Mecarelli L
J Immunol; 1985 Jul; 135(1):440-4. PubMed ID: 3158705
[TBL] [Abstract][Full Text] [Related]
7. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
8. Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase.
Daha MR; van Es LA
J Immunol; 1979 Mar; 122(3):801-5. PubMed ID: 448075
[TBL] [Abstract][Full Text] [Related]
9. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
Saint-Remy JM
Eur J Immunol; 1984 Mar; 14(3):254-9. PubMed ID: 6608450
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; van Es LA
Clin Exp Immunol; 1984 Jun; 56(3):614-20. PubMed ID: 6430610
[TBL] [Abstract][Full Text] [Related]
12. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
Sobel AT; Cooper NR; Schreiber RD
J Immunol; 1979 Jan; 122(1):34-8. PubMed ID: 762421
[TBL] [Abstract][Full Text] [Related]
13. Isolation of C4-binding protein from guinea pig plasma and demonstration of its function as a control protein of the classical complement pathway C3 convertase.
Burge J; Nicholson-Weller A; Austen KF
J Immunol; 1981 Jan; 126(1):232-5. PubMed ID: 6778916
[TBL] [Abstract][Full Text] [Related]
14. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
Thielens NM; Colomb MG
Eur J Immunol; 1986 Jun; 16(6):617-22. PubMed ID: 3487454
[TBL] [Abstract][Full Text] [Related]
15. Relationship between the component and regulatory proteins of the classical pathway C3 convertase.
Welch TR; Forristal J; Beischel L
J Lab Clin Med; 1986 Jun; 107(6):529-33. PubMed ID: 3635565
[TBL] [Abstract][Full Text] [Related]
16. A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition.
Santi P; Joiner KA; Hammer CH; Frank MM; Tosi R
J Immunol; 1987 May; 138(10):3385-91. PubMed ID: 2952716
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
Gigli I; Sorvillo J; Mecarelli-Halbwachs L; Leibowitch J
J Exp Med; 1981 Jul; 154(1):1-12. PubMed ID: 7019379
[TBL] [Abstract][Full Text] [Related]
18. Generation of the classical pathway C3 convertase (EAC4b2a) by proteolytic enzymes.
Loos M; Heinz HP
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():67-74. PubMed ID: 6375257
[TBL] [Abstract][Full Text] [Related]
19. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
Densen P; McRill CM; Ross SC
J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
[TBL] [Abstract][Full Text] [Related]
20. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
Ito S; Tamura N; Fujita T
Immunology; 1989 Dec; 68(4):449-52. PubMed ID: 2481642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]